Postattenuation neurologic signs after surgical correction of congenital portosystemic shunts in cats: A narrative review.
Journal
Veterinary surgery : VS
ISSN: 1532-950X
Titre abrégé: Vet Surg
Pays: United States
ID NLM: 8113214
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
revised:
11
11
2022
received:
22
08
2022
accepted:
18
12
2022
pubmed:
12
1
2023
medline:
25
3
2023
entrez:
11
1
2023
Statut:
ppublish
Résumé
Development of postattenuation neurological signs (PANS) is a potentially severe complication after surgical attenuation of congenital portosystemic shunts in cats. This review summarizes findings of 15 publications that report occurrence of PANS in cats. PANS includes seizures but also milder neurologic signs such as blindness, ataxia, abnormal behavior, tremors, and twitching. Incidence of PANS and specifically postattenuation seizures in studies including a minimum of five cats ranges from 14.3% to 62.0% and 0% to 32.0%, respectively. Etiology of PANS in cats is unknown, however, several hypotheses have been proposed including central nervous system disease/derangement, perioperative hypoglycemia and electrolyte disturbances, and postoperative portal hypertension. A number of possible risk factors have been identified including lower grades of intraoperative postocclusion mesenteric portovenography and osmolality at 24 h postoperatively. Evidence for use of prophylactic antiepileptics such as levetiracetam to prevent or reduce incidence of PANS in cats is limited and does not support their use. Because the cause is unknown, treatment is aimed at controlling neurologic signs, preventing progression to more severe signs, and providing general supportive care. Prospective studies comparing the efficacy of different antiepileptics for treatment of PANS in cats are required. Prognosis for recovery is variable and dependent on severity of neurologic signs. For cats surviving to discharge, long-term survival is possible but persistence or recurrence of neurologic signs in the long-term is not uncommon.
Substances chimiques
Anticonvulsants
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
349-360Informations de copyright
© 2023 The Authors. Veterinary Surgery published by Wiley Periodicals LLC on behalf of American College of Veterinary Surgeons.
Références
Yool DA, Kirby BM. Neurological dysfunction in three dogs and one cat following attenuation of intrahepatic portosystemic shunts. J Small Anim Pract. 2002;43(4):171-176.
Cabassu J, Seim HB, MacPhail CM, Monnet E. Outcomes of cats undergoing surgical attenuation of congenital extrahepatic portosystemic shunts through cellophane banding: 9 cases (2000-2007). J Am Vet Med Assoc. 2011;238(1):89-93.
Wolschrijn CF, Mahapokai W, Rothuizen J, Meyer HP, van Sluijs FJ. Gauged attenuation of congenital portosystemic shunts: results in 160 dogs and 15 cats. Vet Q. 2000;22(2):94-98.
Economu L, Strickland R, Lipscomb VJ. Surgical treatment and outcome of intrahepatic shunts in 12 cats. J Feline Med Surg. 2022;24(10):e411-e419.
Forster-van Hijfte MA, McEvoy FJ, White RN, Lamb CR, Rutgers HC. Per rectal portal scintigraphy in the diagnosis and management of feline congenital portosystemic shunts. J Small Anim Pract. 1996;37(1):7-11.
Brockman D, Brown D, Holt D. Unusual congenital portosystemic communication resulting from persistence of the extrahepatic umbilical vein. J Small Anim Pract. 1998;39(5):244-248.
Heldmann E, Holt DE, Brockman DJ, Brown DC, Perkowski SZ. Use of propofol to manage seizure activity after surgical treatment of portosystemic shunts. J Small Anim Pract. 1999;40(12):590-594.
White RN, Forster-van Hijfte MA, Petrie G, Lamb CR, Hammond RA. Surgical treatment of intrahepatic portosystemic shunts in six cats. Vet Rec. 1996;139(13):314-317.
Lipscomb VJ, Jones HJ, Brockman DJ. Complications and long-term outcomes of the ligation of congenital portosystemic shunts in 49 cats. Vet Rec. 2007;160(14):465-470.
Lipscomb VJ, Lee KC, Lamb CR, Brockman DJ. Association of mesenteric portovenographic findings with outcome in cats receiving surgical treatment for single congenital portosystemic shunts. J Am Vet Med Assoc. 2009;234(2):221-228.
Havig M, Tobias KM. Outcome of ameroid constrictor occlusion of single congenital extrahepatic portosystemic shunts in cats: 12 cases (1993-2000). J Am Vet Med Assoc. 2002;220(3):337-341.
Strickland R, Tivers MS, Fowkes RC, Lipscomb VJ. Incidence and risk factors for neurological signs after attenuation of a single congenital portosystemic shunt in 50 cats. Vet Surg. 2021;50(2):303-311.
Kyles AE, Hardie EM, Mehl M, Gregory CR. Evaluation of ameroid ring constrictors for the management of single extrahepatic portosystemic shunts in cats: 23 cases (1996-2001). J Am Vet Med Assoc. 2002;220(9):1341-1347.
Valiente P, Trehy M, White R, et al. Complications and outcome of cats with congenital extrahepatic portosystemic shunts treated with thin film: thirty-four cases (2008-2017). J Vet Intern Med. 2020;34(1):117-124.
Mullins RA, Escribano Carrera A, Anderson DM, et al. Postattenuation neurologic signs after surgical attenuation of congenital portosystemic shunts in dogs: a review. Vet Surg. 2022;51(1):23-33.
Mullins RA, Sanchez Villamil C, Selmic LE, et al. Prognostic factors for short-term survival of dogs that experience postattenuation seizures after surgical correction of single congenital extrahepatic portosystemic shunts: 93 cases (2005-2018). Vet Surg. 2020;49(5):958-970.
Mullins RA, Sanchez Villamil C, de Rooster H, et al. Effect of prophylactic treatment with levetiracetam on the incidence of postattenuation seizures in dogs undergoing surgical management of single congenital extrahepatic portosystemic shunts. Vet Surg. 2019;48(2):164-172.
Hunt GB, Kummeling A, Tisdall PLC, et al. Outcomes of cellophane banding for congenital portosystemic shunts in 106 dogs and 5 cats. Vet Surg. 2004;33(1):25-31.
Bright SR, Williams JM, Niles JD. Outcomes of intrahepatic portosystemic shunts occluded with ameroid constrictors in nine dogs and one cat. Vet Surg. 2006;35(3):300-309.
Strickland R, Tivers MS, Adamantos SE, Harcourt-Brown TR, Fowkes RC, Lipscomb VJ. Incidence and risk factors for neurological signs after attenuation of single congenital portosystemic shunts in 253 dogs. Vet Surg. 2018;47(6):745-755.
Hunt G, Bellenger C, Pearson M. Transportal approach for attenuating intrahepatic portosystemic shunts in dogs. Vet Surg. 1996;25(4):300-308.
Hardie E, Kornegay J, Cullen J. Status epilepticus after ligation of portosystemic shunts. Vet Surg. 1990;19(6):412-417.
Aronson LR, Gacad RC, Kaminsky-Russ K, Gregory CR, Mullen KD. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts. Vet Surg. 1997;26(3):189-194.
Tivers MS, Handel I, Gow AG, Lipscomb VJ, Jalan R, Mellanby RJ. Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. PLoS One. 2014;9(1):e82303.
Matushek K, Bjorling D, Mathews K. Generalized motor seizures after portosystemic shunt ligation in dogs: five cases (1981-1988). J Am Vet Med Assoc. 1990;196(12):2014-2017.
Mathews K, Gofton N. Congenital extrahepatic portosystemic shunt occlusion in the dog: gross observations during surgical correction. J Am Anim Hosp Assoc. 1988;24:387-394.
Berent A, Tobias KM. Hepatic vascular anomalies. In: Johnston SA, Tobias KM, eds. Veterinary Surgery: Small Animal. 2nd ed. Elsevier Saunders; 2018:1852-1886.
Fryer KJ, Levine JM, Peycke LE, Thompson JA, Cohen ND. Incidence of postoperative seizures with and without levetiracetam pretreatment in dogs undergoing portosystemic shunt attenuation. J Vet Intern Med. 2011;25(6):1379-1384.
Otomo A, Singh A, Jeong J, et al. Long-term clinical outcomes of dogs with single congenital extrahepatic portosystemic shunts attenuated with thin film banding or ameroid ring constrictors. Vet Surg. 2020;49(3):436-444.